» Articles » PMID: 25875151

Laparoscopic Surgery for Colorectal Cancer is Not Associated with an Increase in the Circulating Levels of Several Inflammation-related Factors

Overview
Specialties Oncology
Pharmacology
Date 2015 Apr 16
PMID 25875151
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

It has been hypothesized that inflammatory response triggered by surgery might induce the release of molecules that could promote proliferation, invasion and metastasis of surviving cancer cells. To test this hypothesis, the levels of multiple inflammation-related circulating factors were analyzed in patients undergoing surgery for colorectal cancer. A Luminex xMAP system was used to simultaneously assess levels of IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-17, FGF, eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α and VEGF in 20 colorectal cancer patients and 10 age-matched non-neoplastic patients. In cancer patients analyses were performed at baseline (before surgery) and at different time points (up to 30 days) following laparoscopic surgery. Significantly higher levels of IL-1β, IL-7, IL-8, G-CSF, IFN-γ and TNF-α were detected in colorectal cancer patients compared to controls at baseline. In colorectal cancer patients, circulating levels decreased progressively following surgery and after day 30 post-surgery were no longer different from controls. These findings suggest that expression levels of several cytokines are higher in colorectal cancer patients compared to control subjects and no significant increase in several inflammation-related circulating factors is observed following laparoscopic surgery for cancer. Confirmation and validation in a different and larger cohort of patients are warranted.

Citing Articles

Detection of Cancer Stem Cells from Patient Samples.

Hakala S, Hamalainen A, Sandelin S, Giannareas N, Narva E Cells. 2025; 14(2).

PMID: 39851576 PMC: 11764358. DOI: 10.3390/cells14020148.


Evaluation of the clinical application value of cytokine expression profiles in the differential diagnosis of prostate cancer.

Chen R, Liu L, Chen H, Xing C, Zhang T, Pang Y Cancer Immunol Immunother. 2024; 73(8):139.

PMID: 38833027 PMC: 11150366. DOI: 10.1007/s00262-024-03723-4.


Plasma protein changes reflect colorectal cancer development and associated inflammation.

Urbiola-Salvador V, Jablonska A, Miroszewska D, Huang Q, Duzowska K, Drezek-Chyla K Front Oncol. 2023; 13:1158261.

PMID: 37228491 PMC: 10203952. DOI: 10.3389/fonc.2023.1158261.


Cytokine concentration in peripheral blood of patients with colorectal cancer.

Li W, Chen F, Gao H, Xu Z, Zhou Y, Wang S Front Immunol. 2023; 14:1175513.

PMID: 37063892 PMC: 10098211. DOI: 10.3389/fimmu.2023.1175513.


The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies.

Braumuller H, Mauerer B, Andris J, Berlin C, Wieder T, Kesselring R Cells. 2023; 12(1).

PMID: 36611932 PMC: 9818504. DOI: 10.3390/cells12010138.


References
1.
Guven-Maiorov E, Acuner-Ozbabacan S, Keskin O, Gursoy A, Nussinov R . Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Cancers (Basel). 2014; 6(2):663-83. PMC: 4074797. DOI: 10.3390/cancers6020663. View

2.
Krzystek-Korpacka M, Diakowska D, Kapturkiewicz B, Bebenek M, Gamian A . Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. Cancer Lett. 2013; 337(1):107-14. DOI: 10.1016/j.canlet.2013.05.033. View

3.
Gao F, Liang B, Reddy S, Farias-Eisner R, Su X . Role of inflammation-associated microenvironment in tumorigenesis and metastasis. Curr Cancer Drug Targets. 2013; 14(1):30-45. DOI: 10.2174/15680096113136660107. View

4.
Shiels M, Pfeiffer R, Hildesheim A, Engels E, Kemp T, Park J . Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst. 2013; 105(24):1871-80. PMC: 3888091. DOI: 10.1093/jnci/djt309. View

5.
De Luca A, Lamura L, Gallo M, Maffia V, Normanno N . Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J Cell Biochem. 2012; 113(11):3363-70. DOI: 10.1002/jcb.24212. View